RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Long-Term Results of the RAVE Trial
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 13
SP 15
OP 16
DO 10.1177/155989771113008
UL http://mdc.sagepub.com/content/11/13/15.abstract
AB This article discusses the results of the 18-month follow-up from the Rituximab in ANCA-Associated Vasculitis trial [RAVE; ISRCTN28528813; Stone JH et al. N Engl J Med 2010], which found that one course of treatment with rituximab was noninferior to standard course of therapy (cyclophosphamide followed by azathioprine) for remission-induction of severe antineutrophil cytoplasmic antibody-associated vasculitis.